CTT Pharmaceutical Shares Outstanding vs. Current Ratio

CTTH Stock  USD 0.05  0.0003  0.60%   
Taking into consideration CTT Pharmaceutical's profitability measurements, CTT Pharmaceutical Holdings may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess CTT Pharmaceutical's ability to earn profits and add value for shareholders.
For CTT Pharmaceutical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of CTT Pharmaceutical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well CTT Pharmaceutical Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between CTT Pharmaceutical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of CTT Pharmaceutical Holdings over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between CTT Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if CTT Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CTT Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

CTT Pharmaceutical Current Ratio vs. Shares Outstanding Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining CTT Pharmaceutical's current stock value. Our valuation model uses many indicators to compare CTT Pharmaceutical value to that of its competitors to determine the firm's financial worth.
CTT Pharmaceutical Holdings is rated second in shares outstanding category among its peers. It is number one stock in current ratio category among its peers . The ratio of Shares Outstanding to Current Ratio for CTT Pharmaceutical Holdings is about  4,255,349 . Comparative valuation analysis is a catch-all model that can be used if you cannot value CTT Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for CTT Pharmaceutical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

CTT Current Ratio vs. Shares Outstanding

Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

CTT Pharmaceutical

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
21.32 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

CTT Pharmaceutical

Current Ratio

 = 

Current Asset

Current Liabilities

 = 
5.01 X
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).

CTT Current Ratio Comparison

CTT Pharmaceutical is currently under evaluation in current ratio category among its peers.

CTT Pharmaceutical Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in CTT Pharmaceutical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, CTT Pharmaceutical will eventually generate negative long term returns. The profitability progress is the general direction of CTT Pharmaceutical's change in net profit over the period of time. It can combine multiple indicators of CTT Pharmaceutical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. Ctt Pharmaceutical is traded on OTC Exchange in the United States.

CTT Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on CTT Pharmaceutical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of CTT Pharmaceutical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the CTT Pharmaceutical's important profitability drivers and their relationship over time.

Use CTT Pharmaceutical in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CTT Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CTT Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.

CTT Pharmaceutical Pair Trading

CTT Pharmaceutical Holdings Pair Trading Analysis

The ability to find closely correlated positions to CTT Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CTT Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CTT Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CTT Pharmaceutical Holdings to buy it.
The correlation of CTT Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CTT Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CTT Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CTT Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your CTT Pharmaceutical position

In addition to having CTT Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Realty Funds Thematic Idea Now

Realty Funds
Realty Funds Theme
Funds or Etfs investing in real estate backed instruments or issues backed by different types of commercial properties. The Realty Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Realty Funds Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in CTT Pink Sheet

To fully project CTT Pharmaceutical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of CTT Pharmaceutical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include CTT Pharmaceutical's income statement, its balance sheet, and the statement of cash flows.
Potential CTT Pharmaceutical investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although CTT Pharmaceutical investors may work on each financial statement separately, they are all related. The changes in CTT Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on CTT Pharmaceutical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.